[#item_full_content]
QUTENZA® Phase III Clinical Trial for Post-Surgical Neuropathic Pain Successfully Enrolls Participants, Thanks to Partnership between Grünenthal and Averitas Pharma November 7, 2024
How G-BRIS Streamlines Business Research and Enhances Creditworthiness Assessments for SMEs December 5, 2024
Critical Raw Material Silicon Granted ISCC Carbon Footprint Certification to PCC BakkiSilicon hf. September 4, 2024
